Evidence map›Paper›PMID 26945071›Full record

ArticleThe Journal of biological chemistry2016

Caspase Cleavages of the Lymphocyte-oriented Kinase Prevent Ezrin, Radixin, and Moesin Phosphorylation during Apoptosis.

Catherine Leroy, Natalya V Belkina, Thavy Long, Emeric Deruy, Colette Dissous, Stephen Shaw, David Tulasne

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Knockout ofTranslational cancer research · 2020
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Catherine LeroyFrom the University of Lille, CNRS, Institut Pasteur de Lille, Unité Mixte de Recherche (UMR) 8161, Mechanisms of Tumorigenesis and Target Therapies, 59000 Lille, France.
Natalya V Belkinathe Thoracic and Gastrointestinal Oncology and.
Thavy Longthe University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019-UMR 8204, Center for Infection and Immunity of Lille, 59000 Lille, France.
Emeric Deruythe University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019-UMR 8204, Center for Infection and Immunity of Lille, 59000 Lille, France.
Colette Dissousthe University of Lille, CNRS, INSERM, Centre Hospitalier Régional Universitaire de Lille, Institut Pasteur de Lille, U1019-UMR 8204, Center for Infection and Immunity of Lille, 59000 Lille, France.
Stephen ShawExperimental Immunology Branch Branches, NCI/National Institutes of Health, Bethesda, Maryland 20892, and.
David TulasneFrom the University of Lille, CNRS, Institut Pasteur de Lille, Unité Mixte de Recherche (UMR) 8161, Mechanisms of Tumorigenesis and Target Therapies, 59000 Lille, France.
Université de Lille · FRInserm · FRNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The lymphocyte-oriented kinase (LOK), also called serine threonine kinase 10 (STK10), is synthesized mainly in lymphocytes. It is involved in lymphocyte migration and polarization and can phosphorylate ezrin, radixin, and moesin (the ERM proteins). In a T lymphocyte cell line and in purified human lymphocytes, we found LOK to be cleaved by caspases during apoptosis. The first cleavage occurs at aspartic residue 332, located between the kinase domain and the coiled-coil regulation domain. This cleavage generates an N-terminal fragment, p50 N-LOK, containing the kinase domain and a C-terminal fragment, which is further cleaved during apoptosis. Although these cleavages preserve the entire kinase domain, p50 N-LOK displays no kinase activity. In apoptotic lymphocytes, caspase cleavages of LOK are concomitant with a decrease in ERM phosphorylation. When non-apoptotic lymphocytes from mice with homozygous and heterozygous LOK knockout were compared, the latter showed a higher level of ERM phosphorylation, but when apoptosis was induced, LOK(-/-) and LOK(+/-) lymphocytes showed the same low level, confirming in vivo that LOK-induced ERM phosphorylation is prevented during lymphocyte apoptosis. Our results demonstrate that cleavage of LOK during apoptosis abolishes its kinase activity, causing a decrease in ERM phosphorylation, crucial to the role of the ERM proteins in linking the plasma membrane to actin filaments.

Indexed as

ApoptosisActinsAmino Acid SequenceAnimalsBlotting, WesternCaspasesCell MembraneCells, CulturedCytoskeletal ProteinsCytoskeletonEzrinFemaleHumansImmunoenzyme TechniquesLymphocytesMaleActinsCaspasesCytoskeletal ProteinsEzrinMembrane ProteinsMicrofilament ProteinsmoesinPhosphoproteinsProtein Serine-Threonine KinasesradixinSTK10 protein, humanStk10 protein, mouseapoptosiscaspasecell signalingezrinlymphocyte-oriented kinasemoesinprotein kinaseradixinSTK10

Identifiers

PMID26945071
PMCPMC4858966
OpenAlexW2293038818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.